FRISSORA MARK P 4
4 · BIOADAPTIVES, INC. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
BioAdaptives (BDPT) Director Mark Frissora Receives Preferred Stock Award
What Happened
Mark P. Frissora, a director of BioAdaptives, acquired 4,386 shares of Series D Convertible Preferred Stock on April 1, 2026. The Form 4 reports the transaction as an "other acquisition" (code J) with a reported price of $0.00 — these preferred shares were issued as compensation for board services rather than an open‑market purchase. The securities are convertible into common stock at a ratio of 1 preferred → 100 common, subject to limits described below.
Key Details
- Transaction date: 2026-04-01; filing date: 2026-04-03 (appears timely — filed within two business days).
- Shares acquired: 4,386 shares of Series D Convertible Preferred Stock; reported price $0.00 (compensation).
- Conversion: each preferred converts into 100 shares of common stock (i.e., potentially 438,600 common shares in total), subject to a 4.9% beneficial ownership limitation and a six‑month conversion hold after issuance (conversion permitted earlier only on liquidation).
- Voting: each Series D preferred outstanding is entitled to 100 votes per share at stockholder meetings.
- Source/authority: issued pursuant to the Board of Directors Agreement dated February 3, 2025 (compensation for board services).
- Shares owned after the transaction: not specified in the provided filing.
Context: This was a compensation grant of convertible preferred stock to a director, not a cash purchase or sale. The filing shows $0 as the transaction value because the shares were issued as compensation; any eventual economic value will depend on future conversion and the market price of the common stock, within the stated ownership and timing limits.
Insider Transaction Report
- Other
Series D Convertible Preferred Stock
[F2][F1]2026-04-01+4,386→ 66,746 totalFrom: 2026-10-01→ Common Stock (438,600 underlying)
Footnotes (2)
- [F1]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and theReporting Person.
- [F2]The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares ofcommon stock for each share of Series D Convertible Preferred Stock, subject to a 4.9% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six monthsafter the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting ofstockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.